Christophe Rousselle

Statistics

Publications

Citations

2.3K

H-Index

Active since

1992

Affiliations

Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail(Current)

Inserm

Hôpital Fernand-Widal

German Environment Agency

Federal Institute for Risk Assessment

Christophe Rousselle is an author at Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail specializing in pharmacy, toxicology, and environmental health.

ORCID

Publications per year

1992–2023

Publications

New Advances in the Transport of Doxorubicin through the Blood-Brain Barrier by a Peptide Vector-Mediated Strategy

Christophe Rousselle, Philippe Clair, Jeanne-Marie Lefauconnier et al. · Molecular Pharmacology · 2000 · 340 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Development of an <i>In Situ</i> Mouse Brain Perfusion Model and its Application to <i>mdr1a</i> P-Glycoprotein-Deficient Mice

Claude Dagenais, Christophe Rousselle, Gary M. Pollack et al. · Journal of Cerebral Blood Flow & Metabolism · 2000 · 201 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Enhanced Delivery of Doxorubicin into the Brain via a Peptide-Vector-Mediated Strategy: Saturation Kinetics and Specificity

Christophe Rousselle, Maria Smirnova, Jeanne-Marie Lefauconnier et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 154 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Doxorubicin-peptide conjugates overcome multidrug resistance

Martine Mazel, Philippe Clair, Christophe Rousselle et al. · Anti-Cancer Drugs · 2001 · 120 citations

Medicine, Oncology, Pharmacology +17

Human biomonitoring initiative (HBM4EU) - Strategy to derive human biomonitoring guidance values (HBM-GVs) for health risk assessment

Petra Apel, Christophe Rousselle, Rosa Lange et al. · International Journal of Hygiene and Environmental Health · 2020 · 120 citations · Full text

Pharmacy, Health Policy, Toxicology +16

1–5 of 44